284 related articles for article (PubMed ID: 7824518)
21. [Eosinophilia-myalgia syndrome].
Kotake S; Kashiwazaki S
Nihon Rinsho; 1992 Jul; 50(7):1650-5. PubMed ID: 1404896
[TBL] [Abstract][Full Text] [Related]
22. Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.
de Oliveira JS; Auerbach SB; Sullivan KM; Sale GE
Bone Marrow Transplant; 1993 Feb; 11(2):163-7. PubMed ID: 8435665
[TBL] [Abstract][Full Text] [Related]
23. Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.
Keating JP; Wardill K; Viggiano J
N Z Med J; 1992 Aug; 105(939):317. PubMed ID: 1386918
[No Abstract] [Full Text] [Related]
24. Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan.
Henning KJ; Jean-Baptiste E; Singh T; Hill RH; Friedman SM
J Rheumatol; 1993 Feb; 20(2):273-8. PubMed ID: 8474064
[TBL] [Abstract][Full Text] [Related]
25. [Eosinophilia-myalgia syndrome. Clinical aspects and follow-up of 10 patients].
Mensing H; Schallreuter KU; Senff H; Steinkraus V
Hautarzt; 1992 Jul; 43(7):436-40. PubMed ID: 1506202
[TBL] [Abstract][Full Text] [Related]
26. Eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Analysis of four patients and implications for differential diagnosis and pathogenesis.
Strongwater SL; Woda BA; Yood RA; Rybak ME; Sargent J; DeGirolami U; Smith TW; Varnis C; Allen S; Murphy K
Arch Intern Med; 1990 Oct; 150(10):2178-86. PubMed ID: 2222105
[TBL] [Abstract][Full Text] [Related]
27. [Eosinophilia-myalgia syndrome with fasciitis and interstitial myositis after L-tryptophan administration].
Bartz-Bazzanella P; Genth E; Pollmann HJ; Schröder JM; Völker A
Z Rheumatol; 1992; 51(1):3-13. PubMed ID: 1574934
[TBL] [Abstract][Full Text] [Related]
28. An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan.
Michelson D; Page SW; Casey R; Trucksess MW; Love LA; Milstien S; Wilson C; Massaquoi SG; Crofford LJ; Hallett M
J Rheumatol; 1994 Dec; 21(12):2261-5. PubMed ID: 7699627
[TBL] [Abstract][Full Text] [Related]
29. A case of L-tryptophan-induced eosinophilia-myalgia resulting in death.
Marks DR
Conn Med; 1990 Oct; 54(10):552-4. PubMed ID: 2265542
[TBL] [Abstract][Full Text] [Related]
30. Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome.
Williamson BL; Tomlinson AJ; Mishra PK; Gleich GJ; Naylor S
Chem Res Toxicol; 1998 Mar; 11(3):234-40. PubMed ID: 9544622
[TBL] [Abstract][Full Text] [Related]
31. [Eosinophilia-myalgia syndrome following administration of a L-tryptophan preparation].
Frick P; Frey R
Schweiz Med Wochenschr; 1990 Nov; 120(44):1633-5. PubMed ID: 2251478
[TBL] [Abstract][Full Text] [Related]
32. L-tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis.
Varga J; Jimenez SA; Uitto J
J Invest Dermatol; 1993 Jan; 100(1):97S-105S. PubMed ID: 8423409
[TBL] [Abstract][Full Text] [Related]
33. Tryptophan-induced lung disease: an immunophenotypic, immunofluorescent, and electron microscopic study.
Tazelaar HD; Myers JL; Strickler JG; Colby TV; Duffy J
Mod Pathol; 1993 Jan; 6(1):56-60. PubMed ID: 8426858
[TBL] [Abstract][Full Text] [Related]
34. Review of L-tryptophan and eosinophilia-myalgia syndrome.
Roufs JB
J Am Diet Assoc; 1992 Jul; 92(7):844-50. PubMed ID: 1624654
[TBL] [Abstract][Full Text] [Related]
35. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Bolster MB; Silver RM
Curr Opin Rheumatol; 1994 Nov; 6(6):642-9. PubMed ID: 7865387
[TBL] [Abstract][Full Text] [Related]
36. Eosinophilia-myalgia syndrome in Wisconsin.
Butler JC; Davis JP
Wis Med J; 1990 Dec; 89(12):687-91. PubMed ID: 2293489
[TBL] [Abstract][Full Text] [Related]
37. Tryptophan-induced eosinophilia-myalgia syndrome.
Criswell LA; Sack KE
West J Med; 1990 Sep; 153(3):269-74. PubMed ID: 2219890
[TBL] [Abstract][Full Text] [Related]
38. [L-tryptophan-associated chronic eosinophilia-myalgia syndrome treated with cyclosporin].
Schubert S; Trautmann F; Dreher R
Z Rheumatol; 1992; 51(4):158-62. PubMed ID: 1414039
[TBL] [Abstract][Full Text] [Related]
39. 1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitro.
Zangrilli JG; Mayeno AN; Vining V; Varga J
Biochem Mol Biol Int; 1995 Nov; 37(5):925-33. PubMed ID: 8624499
[TBL] [Abstract][Full Text] [Related]
40. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
Shapiro S
J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]